TAPBPL (Gene)

Synonyms:ENTREZ:55080, HGNC:30683, MIM:607081, NM_001351355, NM_018009, NP_001338284, NP_060479, NR_147126, NR_147127, NR_147128, NR_147129, TAP binding protein like, TAPBP-R, TAPBPL, TAPBPR, XM_005253700, XM_017019545, XM_017019546, XP_005253757, XP_016875034, XP_016875035, XR_001748777, XR_001748778, XR_001748781, XR_002957344, XR_429016
Omim:OMIM:607081
Id:ENSG00000139192
Hgnc:HGNC:30683
Entrez:55080
Description:TAP binding protein like
Tapasin, or TAPBP (MIM 601962), is a member of the variable-constant Ig superfamily that links major histocompatibility complex (MHC) class I molecules to the transporter associated with antigen processing (TAP; see MIM 170260) in the endoplasmic reticulum (ER). The TAPBP gene is located near the MHC complex on chromosome 6p21.3. TAPBPL is a member of the Ig superfamily that is localized on chromosome 12p13.3, a region somewhat paralogous to the MHC.[supplied by OMIM, Mar 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TAPBPL's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TAPBPL.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TAPBPL.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TAPBPL.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TAPBPL.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.